e-Drug3D

2031

M ABROCITINIB


INN
ABROCITINIB

(is an active metabolite)

cas 2744171-53-5
CLASS

DERMATOLOGICALS
TREATMENT OF ATOPIC DERMATITIS
JANUS KINASE 1 (JAK1) INHIBITOR

ROUTE (list)

-

ATC code

D11AH08

PK parameters

PPB 29 PERCENT
t1/2 4 HOUR

Target

TARGET JAK1 KINASE

DrugCentral

Tyrosine-protein kinase JAK1 UNIPROT P23458

Download SDF file 1-Propanesulfonamide, 2-hydroxy-N-[cis-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-, (2R)- (ACI)

Formula:
C14H21N5O3S

Calculated chemical properties:

MW 339.43
NB_atoms 23
XLogP 0.23
PSA 105.841
NB_HD 3
NB_HA 8
fsp3 0.57
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL